Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Clinical trial NCT07071038 · RECRUITING

Trial details

NCT number: NCT07071038
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Adjuvant Treatment Early Stage Breast Cancer

Start date: 2025-10-17
Primary completion: 2026-08-05
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.